IP Library Granted Patent US 7,384,648
Granted Patent B2
US 7,384,648 · App. 11/066,773 · Granted Jun 10, 2008

Implant device with a retinoid for improved biocompatibility

Assignee: Allergan, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,384,648
App. No.
11/066,773
Granted
Jun 10, 2008
Kind
B2
Abstract

An implant device is provided which incorporates a retinoid for improving the biocompatibility of the device in tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a permanent implant which includes a surface treated with a retinoid for increasing the biocompatibility thereof.

Claims (1)

1. A tissue biocompatibility improving retinoid disposed in a retinal plug, said retinal plug having a hole through a proximal end thereof for enabling suturing of said retinal plug to a sclera with a distal end of said retinal plug inserted into a vitreous cavity, said retinoid comprising P-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyll-2-naphthyl)propenyl]-benzoic acid.

Continuity (8)
Continuation 1085340100 · May 24, 2004
Continuation 1039617900 · Mar 24, 2003
Continuation 0998221900 · Oct 17, 2001
Continuation 0958748500 · Jun 5, 2000
Continuation In Part 0935607400 · Jul 16, 1999
Continuation 0915099000 · Sep 10, 1998
Continuation 0890809400 · Aug 11, 1997
Related Publication 20050142165A1 · Jun 30, 2005